| Property | Value |
|---|
|
?:abstract
|
-
Biologics target and inhibit specific cytokines, thereby suppressing the immune system and manifestation of psoriasis. Currently, there exist limited data on the impact of biologics on the coronavirus disease of 2019 (C19). The public may obtain information from many sources which may affect their understanding of biologic use during this pandemic. This study assessed psoriasis patients\' understanding of the safety of biologic use during the C19 pandemic and their perception of various information sources. We recruited 1,104 participants to complete a REDCap survey (survey script is available on request from authors) though Amazon Mechanical Turk, and 281 of these participants fulfilled the following inclusion criteria: diagnosis of psoriasis, age ≥ 18 years, and biologic use for psoriasis.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
|
|
?:journal
|
-
Journal_of_the_European_Academy_of_Dermatology_and_Venereology_:_JEADV
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}